retatrutide phase 2 results obesity nejm 2023 in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 VisualAbstract: Retatrutide reduces body weight
Description
Its primary function is to regulate blood sugar levels by stimulating insulin secretion from the pancreasa crucial factor in maintaining overall metabolic health and flexibility
Excess weight increases intra-abdominal pressure, weakening the lower esophageal sphincter (LES)
Neuroprotective Mechanisms of GLP-1 Receptor Agonists Activation of Classical Signaling Pathways GLP-1 receptors belong to the Gs protein coupled receptor family
Its always best to prioritize health and consult your doctor for alternatives that are safer
This is exactly why physician monitoring is essential throughout your treatment
